Research Topics
| Brent A MooreSummaryAffiliation: Yale University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
The Recovery Line: A pilot trial of automated, telephone-based treatment for continued drug use in methadone maintenanceBrent A Moore
Department of Psychiatry, Yale University School of Medicine, New Haven, CT, 06510, USA APT Foundation, New Haven, CT, 06519, USA Electronic address
J Subst Abuse Treat 45:63-9. 2013..As with other computer-based treatments, findings suggest the Recovery Line is acceptable and feasible. However, additional methods to increase patient utilization of automated systems and larger clinical trials are needed...
Counseling and directly observed medication for primary care buprenorphine maintenance: a pilot studyBrent A Moore
Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, 495 Congress Ave, Second Floor, New Haven, CT 06519, USA
J Addict Med 6:205-11. 2012..Counseling and medication adherence can affect opioid agonist treatment outcomes. We investigated the impact of 2 counseling intensities and 2 medication-dispensing methods in patients receiving buprenorphine in primary care...
Relapse in outpatient treatment for marijuana dependenceBrent A Moore
Department of Psychiatry, University of Vermont, 111 Colchester Avenue, Burlington, VT 05401, USA
J Subst Abuse Treat 25:85-9. 2003..The present data suggest that these similarities extend to difficulty maintaining abstinence...
Computer-based interventions for drug use disorders: a systematic reviewBrent A Moore
Yale University School of Medicine, New Haven, CT, USA
J Subst Abuse Treat 40:215-23. 2011..Evaluation of Internet- and telephone-based delivery that allows for treatment-on-demand in patients' own environment is needed...
Respiratory effects of marijuana and tobacco use in a U.S. sampleBrent A Moore
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA
J Gen Intern Med 20:33-7. 2005..The current study examined respiratory effects of marijuana and tobacco use in a nationally representative sample while controlling for age, gender, and current asthma...
Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patientsBrent A Moore
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
J Gen Intern Med 22:527-30. 2007..Prescription opioid dependence is increasing, but treatment outcomes with office-based buprenorphine/naloxone among these patients have not been described...
Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 yearsDavid A Fiellin
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8025, USA
Am J Addict 17:116-20. 2008..Serum transaminases remained stable from baseline. No serious adverse events related to treatment occurred. We conclude that select opioid-dependent patients exhibit moderate levels of retention in primary care office-based treatment...
Patient satisfaction with primary care office-based buprenorphine/naloxone treatmentDeclan T Barry
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519 1187, USA
J Gen Intern Med 22:242-5. 2007..Factors associated with satisfaction among patients receiving primary care-based buprenorphine/naloxone are unknown...
Use of conventional, complementary, and alternative treatments for pain among individuals seeking primary care treatment with buprenorphine-naloxoneDeclan T Barry
Yale University School of Medicine, New Haven, CT 06519, USA
J Addict Med 6:274-9. 2012..Previous studies have not examined patterns of pain treatment use among patients seeking office-based buprenorphine-naloxone treatment (BNT) for opioid dependence...
A trial of integrated buprenorphine/naloxone and HIV clinical careLynn E Sullivan
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, USA
Clin Infect Dis 43:S184-90. 2006..We investigated the feasibility and efficacy of integrating buprenorphine, along with 2 levels of counseling, into HIV clinical care...
The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependenceLynn E Sullivan
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8093, USA
Am J Addict 19:53-8. 2010..35%, p = .001). We conclude that both baseline and in-treatment cocaine use is associated with worse treatment outcomes in patients receiving office-based buprenorphine/naloxone and may benefit from targeted interventions...
Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviorsLynn E Sullivan
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
J Subst Abuse Treat 35:87-92. 2008..We conclude that primary-care-based buprenorphine/naloxone treatment is associated with decreased drug-related HIV risk, but additional efforts may be needed to address sex-related HIV risk when present...
Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patientsJeanette M Tetrault
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510, USA
J Subst Abuse Treat 43:433-9. 2012..84 and p=.27 for the interaction). Providing more extensive counseling beyond PM is feasible in an HIV clinic, but we are unable to detect an improvement in outcomes associated with these services...
A randomized trial of cognitive behavioral therapy in primary care-based buprenorphineDavid A Fiellin
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
Am J Med 126:74.e11-7. 2013..To determine the impact of cognitive behavioral therapy on outcomes in primary care, office-based buprenorphine/naloxone treatment of opioid dependence...
Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependenceDavid A Fiellin
Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn 06520, USA
N Engl J Med 355:365-74. 2006..The optimal level of counseling and frequency of attendance for medication distribution has not been established for the primary care, office-based buprenorphine-naloxone treatment of opioid dependence...
Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patientsEmlyn S Jones
Department of Internal Medicine, Section of General Internal Medicine, Yale University School of Medicine, 333 Cedar St, P O Box 208025, New Haven, CT, United States
Drug Alcohol Depend 99:132-40. 2009..We conclude that providing clinic-based methadone is least expensive. The price of buprenorphine accounts for a major portion of the difference in costs. For patients, office-based treatment may be less expensive...
Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptomsAlan J Budney
Department of Psychiatry, University of Arkansas for Medical Sciences, 4301 W Markham, Little Rock, AR 72205, USA
Drug Alcohol Depend 86:22-9. 2007..The primary aims were to establish the pharmacological specificity of the withdrawal syndrome and to obtain information relevant to determining the potential use of THC to assist in the treatment of cannabis dependence...
Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxoneEmily A Wang
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510, USA
J Gen Intern Med 25:670-4. 2010..Behaviors associated with opioid dependence often involve criminal activity, which can lead to incarceration. The impact of a history of incarceration on outcomes in primary care office-based buprenorphine/naloxone is not known...
Pain and Associated Substance Use among Opioid Dependent Individuals Seeking Office-Based Treatment with Buprenorphine-Naloxone: A Needs Assessment StudyDeclan T Barry
Yale University School of Medicine, New Haven, Connecticut The APT Foundation Pain Treatment Services, New Haven, Connecticut
Am J Addict 22:212-7. 2013..e., recent pain, chronic pain), (b) the characteristics of pain (intensity, frequency, duration, interference, location, and genesis), and (c) substance use to alleviate pain...
Human immunodeficiency virus testing practices among buprenorphine-prescribing physiciansE Jennifer Edelman
Robert Wood Johnson Foundation Clinical Scholars Program, Yale School of Public Health, New Haven, CT 06520, USA
J Addict Med 6:159-65. 2012....
A cross-study comparison of cannabis and tobacco withdrawalRyan G Vandrey
Department of Psychiatry, University of Vermont, South Burlington, VT 05403, USA
Am J Addict 14:54-63. 2005..These findings are consistent with other evidence supporting the clinical importance of the cannabis withdrawal syndrome. There remains a need for prospective experimental studies to replicate these findings...
Review of the validity and significance of cannabis withdrawal syndromeAlan J Budney
Department of Psychiatry, University of Vermont, 54 W Twin Oaks Terrace, Suite 12, S Burlington, VT 05403, USA
Am J Psychiatry 161:1967-77. 2004..The magnitude and severity of these symptoms appear substantial, and these findings suggest that the syndrome has clinical importance. Diagnostic criteria for cannabis withdrawal syndrome are proposed...
Examining the influence of clinician decision making on adherence to a clinical guidelinePaul R Falzer
Clinical Epidemiology Research Center, Department of Veterans Affairs, Connecticut Healthcare System, 950 Campbell Ave, Building 35A, Mailcode 151B, West Haven, CT 06516, USA
Psychiatr Serv 60:698-701. 2009..The study presented here attempted to account for this low rate by using clinical vignettes to manipulate key factors...
Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic reviewJeanette M Tetrault
Clinical Epidemiology Research Center, Department of Veterans Affairs Connecticut Healthcare System, West Haven Veterans Affairs Medical Center, 950 Campbell Avenue, West Haven, CT 06516, USA
Arch Intern Med 167:221-8. 2007....
Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependenceAlan J Budney
Department of Psychiatry, University of Vermont, Burlington, VT, USA
J Consult Clin Psychol 74:307-16. 2006..Discussion focuses on the strengths of each intervention, the clinical significance of the findings, and the need to continue efforts toward development of effective interventions...
Prevalence of chronic kidney disease in an urban HIV infected populationSanjay K Fernando
Section of Nephrology, Department of Medicine, Hospital of Saint Raphael, New Haven, Connecticut, USA
Am J Med Sci 335:89-94. 2008..The prevalence of chronic kidney disease in an HIV-infected population during the highly active antiretroviral era has not been fully evaluated...
Personality disorders and retention in a therapeutic community for substance dependenceDouglas B Samuel
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
Am J Addict 20:555-62. 2011..Early assessment and identification of at-risk individuals may improve treatment retention and outcome for TC treatment...
Comparison of the microbiological efficacy of hydrogen peroxide vapor and ultraviolet light processes for room decontaminationNancy L Havill
Hospital of Saint Raphael, New Haven, Connecticut 06511, USA
Infect Control Hosp Epidemiol 33:507-12. 2012..To compare the microbiological efficacy of hydrogen peroxide vapor (HPV) and ultraviolet radiation (UVC) for room decontamination...
Development and consequences of cannabis dependenceAlan J Budney
Department of Psychiatry, University of Vermont, South Burlington 05403, USA
J Clin Pharmacol 42:28S-33S. 2002..This report briefly reviews selected research literature relevant to our current understanding of cannabis dependence, its associated consequences, and treatment efficacy...
The time course and significance of cannabis withdrawalAlan J Budney
Department of Psychiatry, University of Vermont, South Burlington 05403, USA
J Abnorm Psychol 112:393-402. 2003..These effects likely contribute to the development of dependence and difficulty stopping use. Criteria for cannabis withdrawal are proposed...
Routine anal cytology screening for anal squamous intraepithelial lesions in an urban HIV clinicHyman Scott
Yale University School of Medicine, Hospital of Saint Raphael, New Haven, Connecticut, USA
Sex Transm Dis 35:197-202. 2008....
Counselors' Experiences Treating Methadone-maintained Patients with Chronic Pain: A Needs Assessment StudyDeclan T Barry
From the Department of Psychiatry DTB, MB, BAM, RDK, RSS, Yale University School of Medicine, New Haven, CT and The APT Foundation MJB, New Haven, CT
J Addict Med 2:108-11. 2008....
Comparison of fluorescent marker systems with 2 quantitative methods of assessing terminal cleaning practicesJohn M Boyce
Hospital of Saint Raphael, New Haven, Connecticut 06511, USA
Infect Control Hosp Epidemiol 32:1187-93. 2011..To compare fluorescent markers with aerobic colony counts (ACCs) and an adenosine triphosphate (ATP) bioluminescence assay system for assessing terminal cleaning practices...
Abstinence at intake for marijuana dependence treatment predicts responseBrent A Moore
Department of Psychiatry, Treatment Research Center, University of Vermont, 56 W Twin Oaks Terrace, Suite 9, S Burlington, VT 05403, USA
Drug Alcohol Depend 67:249-57. 2002..Clinical trials might consider including pretreatment abstinence status as a stratification variable during participant assignment or as a covariate in outcome analyses...
The association between marijuana smoking and lung cancer: a systematic reviewReena Mehra
Department of Medicine, Case Western Reserve University, Cleveland, Ohio 44106 6003, USA
Arch Intern Med 166:1359-67. 2006..Our objective was to assess the impact of marijuana smoking on the development of premalignant lung changes and lung cancer...
Research Grants
- Selegiline for Treatment of Cannabis DependenceBRENT MOORE; Fiscal Year: 2005..Study findings will also be important in exploring potential mechanism of action of selegiline and establishing a program of research to evaluate medications for cannabis-dependence. ..
